# Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung

> **NCT03808662** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 107 (actual)

## Conditions studied

- TNBC - Triple-Negative Breast Cancer
- Triple Negative Breast Cancer
- NSCLC
- NSCLC Stage IV
- Non Small Cell Lung Cancer
- Non Small Cell Lung Cancer Metastatic
- NSCLC Stage IV Without EGFR/ALK Mutation

## Interventions

- **RADIATION:** Sterotactic Body Radiotherapy/SBRT
- **DRUG:** Standard of care

## Key facts

- **NCT ID:** NCT03808662
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-01-16
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03808662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03808662, "Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and Lung". Retrieved via AI Analytics 2026-05-19 from https://api.ai-analytics.org/clinical/NCT03808662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*